The POI Industry Advisory Board (IAB) consists of representatives from each of our industry partners and provides the following supports to our strategic direction;
- Provides guidance to the POI Governance Committee and Executive Committee on matters relating to industry involvement in POI as well as industry trends which may inform POI’s strategic direction.
- Advises and supports POI in terms of developing and expanding mutually beneficial relationships with the industry sector.
- Identification of funding opportunities which may support POI’s growth as a consortium, and support the operations team in the pursuit of obtaining such funds.
- Promoting POI as an innovative research programme for Ireland.
Current and past IAB board members
- Mr. Tommy Bracken (Hexagon Consulting, CRC-UCD and Chairperson, POI IAB)
- Dr. Claus Bendtsen (AstraZeneca)
- Dr. Steven Griffin (Cell Stress Discoveries)
- Dr. David Kavanagh (Genuity Science)
- Dr. Remco Loos (Celgene)
- Dr. Helen McCarty (Phion Therapeutics)
- Mr. Des O’Leary (OncoMark)
- Mr. Padraig Somers (Helsinn)